![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 471/04 | |
A61K 31/437 | |||
A61K 31/444 | |||
A61P 35/00 |
(11) | Number of the document | 3461823 |
(13) | Kind of document | T |
(96) | European patent application number | 17812632.2 |
Date of filing the European patent application | 2017-06-09 | |
(97) | Date of publication of the European application | 2019-04-03 |
(45) | Date of publication and mention of the grant of the patent | 2020-06-03 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2017/087711 |
Date | 2017-06-09 |
(87) | Number | WO 2017/215521 |
Date | 2017-12-21 |
(30) | Number | Date | Country code |
201610430773 | 2016-06-17 | CN |
(72) |
CHEN, Minhua, CN
ZHANG, Yanfeng, CN
ZOU, Po, CN
ZHANG, Xiaoyu, CN
|
(73) |
Crystal Pharmaceutical (Suzhou) Co., Ltd.,
B4-301 Biobay 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215123,
CN
|
(54) | PEXIDARTINIB HYDROCHLORIDE CRYSTAL FORMS, PREPARATION METHOD THEREFOR AND USE THEREOF |
PEXIDARTINIB HYDROCHLORIDE CRYSTAL FORMS, PREPARATION METHOD THEREFOR AND USE THEREOF |